Exact Mass: 280.1203

Exact Mass Matches: 280.1203

Found 99 metabolites which its exact mass value is equals to given mass value 280.1203, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

cyclopeptine

(3S)-3-benzyl-4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione

C17H16N2O2 (280.1212)


   
   

Hymenoside W

Hymenoside W

C11H20O8 (280.1158)


   
   

3-(Methoxycarbonyl)propyl-beta-D-glucopyranoside

3-(Methoxycarbonyl)propyl-beta-D-glucopyranoside

C11H20O8 (280.1158)


   
   

N-benzyl-5-methoxy-1H-indole-2-carboxamide

N-benzyl-5-methoxy-1H-indole-2-carboxamide

C17H16N2O2 (280.1212)


   
   

Cardiomanol

Cardiomanol

C11H20O8 (280.1158)


   

methyl (S)-3-[(beta-D-glucopyranosyl)oxy]butyrate

methyl (S)-3-[(beta-D-glucopyranosyl)oxy]butyrate

C11H20O8 (280.1158)


   

3-(methoxycarbonyl)propyl beta-D-glucopyranoside|3-(Methoxycarbonyl)propyl-??-D-glucopyranoside

3-(methoxycarbonyl)propyl beta-D-glucopyranoside|3-(Methoxycarbonyl)propyl-??-D-glucopyranoside

C11H20O8 (280.1158)


   
   

SCHEMBL14097214

SCHEMBL14097214

C11H20O8 (280.1158)


   

4-O-beta-Xylopyranosyl-D-digitoxose

4-O-beta-Xylopyranosyl-D-digitoxose

C11H20O8 (280.1158)


   

1-Methyl-3-phenethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione

1-Methyl-3-phenethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione

C17H16N2O2 (280.1212)


   

C17H16N2O2_1H-1,4-Benzodiazepine-2,5-dione, 3,4-dihydro-4-methyl-3-(phenylmethyl)

NCGC00180043-02_C17H16N2O2_1H-1,4-Benzodiazepine-2,5-dione, 3,4-dihydro-4-methyl-3-(phenylmethyl)-

C17H16N2O2 (280.1212)


   

2,7-Acetylaminofluorene

2,7-diacetylaminofluorene

C17H16N2O2 (280.1212)


CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3700; ORIGINAL_PRECURSOR_SCAN_NO 3699 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3693; ORIGINAL_PRECURSOR_SCAN_NO 3691 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3704; ORIGINAL_PRECURSOR_SCAN_NO 3702 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3695; ORIGINAL_PRECURSOR_SCAN_NO 3693 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3770; ORIGINAL_PRECURSOR_SCAN_NO 3769 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3701; ORIGINAL_PRECURSOR_SCAN_NO 3699 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7611; ORIGINAL_PRECURSOR_SCAN_NO 7609 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7638; ORIGINAL_PRECURSOR_SCAN_NO 7636 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7662; ORIGINAL_PRECURSOR_SCAN_NO 7660 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7671; ORIGINAL_PRECURSOR_SCAN_NO 7669 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7650; ORIGINAL_PRECURSOR_SCAN_NO 7649 CONFIDENCE standard compound; INTERNAL_ID 425; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7674; ORIGINAL_PRECURSOR_SCAN_NO 7672

   

Hexanal,2-(2,4-dinitrophenyl)hydrazone

Hexanal,2-(2,4-dinitrophenyl)hydrazone

C12H16N4O4 (280.1171)


   

3-BENZYL-IMIDAZO[1,5-A]PYRIDINE-1-CARBOXYLIC ACID ETHYL ESTER

3-BENZYL-IMIDAZO[1,5-A]PYRIDINE-1-CARBOXYLIC ACID ETHYL ESTER

C17H16N2O2 (280.1212)


   

(2S,4S)-4-Boc-Amino pyrrolidine-2-carboxylic acid methylester hydrochloride

(2S,4S)-4-Boc-Amino pyrrolidine-2-carboxylic acid methylester hydrochloride

C11H21ClN2O4 (280.119)


   

2-AMINO-4-METHOXY-7-(BETA-D-2-DEOXYRIBOFURANOSYL)PYRROLO[2,3-D]PYRIMIDINE

2-AMINO-4-METHOXY-7-(BETA-D-2-DEOXYRIBOFURANOSYL)PYRROLO[2,3-D]PYRIMIDINE

C12H16N4O4 (280.1171)


   

(R)-4-N-BOC-PIPERAZINE-2-CARBOXYLIC ACID METHYL ESTER-HCl

(R)-4-N-BOC-PIPERAZINE-2-CARBOXYLIC ACID METHYL ESTER-HCl

C11H21ClN2O4 (280.119)


   

Azabon

4-(3-azabicyclo[3.2.2]nonan-3-ylsulfonyl)aniline

C14H20N2O2S (280.1245)


C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   
   

2,4-Imidazolidinedione,5,5-bis(phenylmethyl)-

2,4-Imidazolidinedione,5,5-bis(phenylmethyl)-

C17H16N2O2 (280.1212)


   

5-METHYL-2-NAPHTHALEN-1-YL-3H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER

5-METHYL-2-NAPHTHALEN-1-YL-3H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER

C17H16N2O2 (280.1212)


   

2-METHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3-NITROPYRIDINE

2-METHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3-NITROPYRIDINE

C12H17BN2O5 (280.123)


   

2-Methoxy-5-nitropyridine-3-boronic acid pinacol ester

2-Methoxy-5-nitropyridine-3-boronic acid pinacol ester

C12H17BN2O5 (280.123)


   

3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHANOL

3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHANOL

C17H16N2O2 (280.1212)


   

Ethyl 3-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl) propanoate

Ethyl 3-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl) propanoate

C12H16N4O4 (280.1171)


   

bis(trimethylsilyl)hypoxathine

bis(trimethylsilyl)hypoxathine

C11H20N4OSi2 (280.1176)


9-(Trimethylsilyl)-6-[(trimethylsilyl)oxy]-9H-purine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=17962-89-9 (retrieved 2024-09-24) (CAS RN: 17962-89-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   
   

2-Fluoro-5-(Methoxycarbonyl)benzeneboronic acid pinacol ester

2-Fluoro-5-(Methoxycarbonyl)benzeneboronic acid pinacol ester

C14H18BFO4 (280.1282)


   

1-Phenyl-3-[(phenylmethyl)amino]-2,5-pyrrolidinedione

1-Phenyl-3-[(phenylmethyl)amino]-2,5-pyrrolidinedione

C17H16N2O2 (280.1212)


   

(S)-N-Cbz-Phenylalaninenitrile

(S)-N-Cbz-Phenylalaninenitrile

C17H16N2O2 (280.1212)


   

METHYL (2R,4S)-4-BOC-AMINOPYRROLIDINE-2-CARBOXYLATE HYDROCHLORIDE

METHYL (2R,4S)-4-BOC-AMINOPYRROLIDINE-2-CARBOXYLATE HYDROCHLORIDE

C11H21ClN2O4 (280.119)


   

1-(4-aminobenzoyl)-3,4-dihydro-2H-1-benzazepin-5-one

1-(4-aminobenzoyl)-3,4-dihydro-2H-1-benzazepin-5-one

C17H16N2O2 (280.1212)


   

Ethyl 6-amino-2-phenyl-1H-indole-3-carboxylate

Ethyl 6-amino-2-phenyl-1H-indole-3-carboxylate

C17H16N2O2 (280.1212)


   

(S)-1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride

(S)-1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride

C11H21ClN2O4 (280.119)


   

N-Boc-cis-4-Amino-L-proline methyl ester hydrochloride

N-Boc-cis-4-Amino-L-proline methyl ester hydrochloride

C11H21ClN2O4 (280.119)


   

METHYL 3-FLUORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE

METHYL 3-FLUORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE

C14H18BFO4 (280.1282)


   

Benzoic acid, 5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, Methyl ester

Benzoic acid, 5-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, Methyl ester

C14H18BFO4 (280.1282)


   

1-amino-4-[(1-methylethyl)amino]anthraquinone

1-amino-4-[(1-methylethyl)amino]anthraquinone

C17H16N2O2 (280.1212)


   

N-Boc-trans-4-amino-L-proline methyl ester hydrochloride

N-Boc-trans-4-amino-L-proline methyl ester hydrochloride

C11H21ClN2O4 (280.119)


   

1-(trans-2-Phenylethenyl)-4-(p

1-(trans-2-Phenylethenyl)-4-(p

C22H16 (280.1252)


   

3-Fluoro-4-(Methoxycarbonyl)benzeneboronic acid pinacol ester

3-Fluoro-4-(Methoxycarbonyl)benzeneboronic acid pinacol ester

C14H18BFO4 (280.1282)


   

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid hydrochloride

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid hydrochloride

C11H21ClN2O4 (280.119)


   

(2S)-2,6-diaminohexanoic acid,(2S)-2-hydroxybutanedioic acid

(2S)-2,6-diaminohexanoic acid,(2S)-2-hydroxybutanedioic acid

C10H20N2O7 (280.127)


   

2-(4-BENZYLOXY-PHENYL)-OXAZOL-4-YL-METHYLAMINE

2-(4-BENZYLOXY-PHENYL)-OXAZOL-4-YL-METHYLAMINE

C17H16N2O2 (280.1212)


   

(E)-3-Cyclopentyl-2-(4-(methylsulfonyl)phenyl)prop-2-en-1-ol

(E)-3-Cyclopentyl-2-(4-(methylsulfonyl)phenyl)prop-2-en-1-ol

C15H20O3S (280.1133)


   

1-(Phenylsulfonyl)-1,8-diazaspiro[4.5]decane

1-(Phenylsulfonyl)-1,8-diazaspiro[4.5]decane

C14H20N2O2S (280.1245)


   

trimethyl-[2-(4-phenylmethoxyphenyl)ethynyl]silane

trimethyl-[2-(4-phenylmethoxyphenyl)ethynyl]silane

C18H20OSi (280.1283)


   

Ethyl 1-benzyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

Ethyl 1-benzyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylate

C17H16N2O2 (280.1212)


   

1,3-Piperazinedicarboxylic acid, 1-(1,1-dimethylethyl) 3-methyl ester, hydrochloride (1:1), (3S)-

1,3-Piperazinedicarboxylic acid, 1-(1,1-dimethylethyl) 3-methyl ester, hydrochloride (1:1), (3S)-

C11H21ClN2O4 (280.119)


   

1H-Indole-3-acetamide,5-(phenylmethoxy)-

1H-Indole-3-acetamide,5-(phenylmethoxy)-

C17H16N2O2 (280.1212)


   

4,4-Azobis(4-cyanovaleric acid)

4,4-Azobis(4-cyanovaleric acid)

C12H16N4O4 (280.1171)


   

Methyl 3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Methyl 3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

C14H18BFO4 (280.1282)


   

6-[5-(4-methoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-4-methylcyclohexa-2,4-dien-1-one

6-[5-(4-methoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-4-methylcyclohexa-2,4-dien-1-one

C17H16N2O2 (280.1212)


   

Dimethylbenzo[a]pyrene

Dimethylbenzo[a]pyrene

C22H16 (280.1252)


   

Dimethylbenzo[e]pyrene

Dimethylbenzo[e]pyrene

C22H16 (280.1252)


   

(2R,4R)-Methyl 4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylate hydrochloride

(2R,4R)-Methyl 4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylate hydrochloride

C11H21ClN2O4 (280.119)


   

4-Fluoro-3-methoxycarbonylphenylboronic acid pinacol ester

4-Fluoro-3-methoxycarbonylphenylboronic acid pinacol ester

C14H18BFO4 (280.1282)


   

6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]-pyridine-3-acetic acid

6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]-pyridine-3-acetic acid

C17H16N2O2 (280.1212)


   

(2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL

(2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL

C11H21ClN2O4 (280.119)


   

CIS-9-STYRYLANTHRACENE

CIS-9-STYRYLANTHRACENE

C22H16 (280.1252)


   

4-(PIPERIDIN-1-YL)-8-(TRIFLUOROMETHYL)QUINOLINE

4-(PIPERIDIN-1-YL)-8-(TRIFLUOROMETHYL)QUINOLINE

C15H15F3N2 (280.1187)


   

Opaviraline

Opaviraline

C14H17FN2O3 (280.1223)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

Parachlorophenol, Camphorated

Parachlorophenol, Camphorated

C16H21ClO2 (280.123)


D000890 - Anti-Infective Agents D004202 - Disinfectants

   

9-(6-Deoxy-alpha-L-talofuranosyl)-6-methylpurine

9-(6-Deoxy-alpha-L-talofuranosyl)-6-methylpurine

C12H16N4O4 (280.1171)


   

9-(6-Deoxy-beta-D-allofuranosyl)-6-methylpurine

9-(6-Deoxy-beta-D-allofuranosyl)-6-methylpurine

C12H16N4O4 (280.1171)


   

2-(1H-indol-3-ylamino)-3-phenylpropanoic acid

2-(1H-indol-3-ylamino)-3-phenylpropanoic acid

C17H16N2O2 (280.1212)


   

4-(4-hydroxy-3,5-dimethylphenyl)-2-methylphthalazin-1(2H)-one

4-(4-hydroxy-3,5-dimethylphenyl)-2-methylphthalazin-1(2H)-one

C17H16N2O2 (280.1212)


   

4-(2-hydroxyphenyl)-8,9-dimethyl-2,3-dihydro-1H-1,5-benzodiazepin-2-one

4-(2-hydroxyphenyl)-8,9-dimethyl-2,3-dihydro-1H-1,5-benzodiazepin-2-one

C17H16N2O2 (280.1212)


   

3-[(4-methoxyanilino)methyl]-1H-quinolin-2-one

3-[(4-methoxyanilino)methyl]-1H-quinolin-2-one

C17H16N2O2 (280.1212)


   

3-(4-Methoxyphenyl)-5-(2-phenylethyl)-1,2,4-oxadiazole

3-(4-Methoxyphenyl)-5-(2-phenylethyl)-1,2,4-oxadiazole

C17H16N2O2 (280.1212)


   

4-[(3,5-Dimethylphenyl)-oxomethyl]-1,3-dihydroquinoxalin-2-one

4-[(3,5-Dimethylphenyl)-oxomethyl]-1,3-dihydroquinoxalin-2-one

C17H16N2O2 (280.1212)


   

N-[2-[2,3-dihydroindol-1-yl(oxo)methyl]phenyl]acetamide

N-[2-[2,3-dihydroindol-1-yl(oxo)methyl]phenyl]acetamide

C17H16N2O2 (280.1212)


   

2-(3-imino-1H-isoindol-2-yl)-1-(4-methoxyphenyl)ethanone

2-(3-imino-1H-isoindol-2-yl)-1-(4-methoxyphenyl)ethanone

C17H16N2O2 (280.1212)


   

(3S)-3-benzyl-4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione

(3S)-3-benzyl-4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione

C17H16N2O2 (280.1212)


   

MK-0608

MK-0608

C12H16N4O4 (280.1171)


MK-0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC50 of 0.3 μM (EC90=1.3 μM) in the subgenomic-replicon assay[1].

   

N-Salicyloyltryptamine

N-Salicyloyltryptamine

C17H16N2O2 (280.1212)


N-Salicyloyltryptamine acts on voltage-dependent Na+, Ca2+, and K+ ion channels inhibitor. N-Salicyloyltryptamine inhibits K+ currents with an IC50 value of 34.6 μM (Ito). N-Salicyloyltryptamine also exhibits anticonvulsant, anti-inflammatory, analgesic, and vasorelaxation effect[1]-[5].

   

(2r,3r,4s,5r,6r)-2-[(3s)-3,4-dihydroxy-2-methylidenebutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-[(3s)-3,4-dihydroxy-2-methylidenebutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C11H20O8 (280.1158)


   

(1r,2s,5r)-5-[(8r)-8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl]-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol

(1r,2s,5r)-5-[(8r)-8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl]-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol

C12H16N4O4 (280.1171)


   

1-methyl-3-(2-phenylethyl)quinazoline-2,4-dione

1-methyl-3-(2-phenylethyl)quinazoline-2,4-dione

C17H16N2O2 (280.1212)


   

3-(methoxycarbonyl)propyl-β-d-glucopyra-noside

NA

C11H20O8 (280.1158)


{"Ingredient_id": "HBIN008821","Ingredient_name": "3-(methoxycarbonyl)propyl-\u03b2-d-glucopyra-noside","Alias": "NA","Ingredient_formula": "C11H20O8","Ingredient_Smile": "COC(=O)CCCOC1C(C(C(C(O1)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13870","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r,3r,4s,5s,6r)-2-(3,4-dihydroxy-2-methylidenebutoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-(3,4-dihydroxy-2-methylidenebutoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C11H20O8 (280.1158)


   

(3z,9z,11e)-6-chlorotetradeca-3,9,11-trien-1-yn-7-yl acetate

(3z,9z,11e)-6-chlorotetradeca-3,9,11-trien-1-yn-7-yl acetate

C16H21ClO2 (280.123)


   

(11e)-6-chlorotetradeca-3,9,11-trien-1-yn-7-yl acetate

(11e)-6-chlorotetradeca-3,9,11-trien-1-yn-7-yl acetate

C16H21ClO2 (280.123)


   

(2r,3r,4r,5r,6r)-2-[(3s)-3,4-dihydroxy-2-methylidenebutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5r,6r)-2-[(3s)-3,4-dihydroxy-2-methylidenebutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C11H20O8 (280.1158)


   

(3r,4r)-3-(hepta-1,3,5-triyn-1-yl)-4-[(1e)-non-1-en-3,5,7-triyn-1-yl]cyclohex-1-ene

(3r,4r)-3-(hepta-1,3,5-triyn-1-yl)-4-[(1e)-non-1-en-3,5,7-triyn-1-yl]cyclohex-1-ene

C22H16 (280.1252)


   

(1s,2r,5r)-5-{8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl}-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol

(1s,2r,5r)-5-{8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl}-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol

C12H16N4O4 (280.1171)


   

3-(hepta-1,3,5-triyn-1-yl)-4-(non-1-en-3,5,7-triyn-1-yl)cyclohex-1-ene

3-(hepta-1,3,5-triyn-1-yl)-4-(non-1-en-3,5,7-triyn-1-yl)cyclohex-1-ene

C22H16 (280.1252)


   

(2r,3r,4r,5s,6r)-2-(3,4-dihydroxy-2-methylidenebutoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5s,6r)-2-(3,4-dihydroxy-2-methylidenebutoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C11H20O8 (280.1158)


   

methyl 3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoate

methyl 3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoate

C11H20O8 (280.1158)


   

methyl (3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoate

methyl (3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoate

C11H20O8 (280.1158)


   

4-(3-methylbut-2-en-1-yl)phenazine-1,6-diol

4-(3-methylbut-2-en-1-yl)phenazine-1,6-diol

C17H16N2O2 (280.1212)


   

5-{8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl}-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol

5-{8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl}-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol

C12H16N4O4 (280.1171)


   

10-methoxy-2-methyl-6h,7h,12h-indolo[2,3-a]quinolizin-4-one

10-methoxy-2-methyl-6h,7h,12h-indolo[2,3-a]quinolizin-4-one

C17H16N2O2 (280.1212)